Abstract
Aims: To evaluate the value of 99mTc-labeled mono-clonal Fab antibodies (Leukoscan) in the diagnosis of septic loosening of total hip arthroplasty (THA). Methods: 16 patients (mean age 63.2 years) with hip arthroplasty (5 hemi,9 cementless,2 cemented THAs) were investigated for deep infection with the use of Leukoscan. Patient selection was based on a “high-risk protocol”. All patients were clinically evaluated using modified HHS and each patient’s workout included x-rays, WBC, ESR, CRP, dynamic bone scan 99mTc-MDP and Leukoscan. Two (2) patients were treated by wide debridement and continuous lavage,6 with revision surgery and 8 with Girdlestone. Histologic samples and cultures were received and their results were compared with Leukoscan’s findings. Results: Preoperative evaluation of the patients revealed as major risk factors:pathologic blood tests (16), previous surgical interventions (13), implant loosening (8), wound infection (7). Mean mHHS was 58 (28–80), mean ESR 51 (23–87 mm/h), mean CRP 4,1 (0,9–18 mg/dl). Bone scans were evaluated as 15 positive and 1 negative and they were matched with 15 positive and 1 negative Leukoscan respectively. Twelve (12) positive histopathologic results and 2 positive tissue cultures were matched with 14 positive Leukoscans, while 1 positive Leukoscan was not verified by positive histopathologic findings of chronic infection. Bacteriae identified were: S.epidermidis 5x, S.aureus 2x, Escherichia Coli 1x, S.saprophyticus 1x, Klebsiella pneumoniae 1x. Conclusions: Leukoscan seems to offer a reliable diagnostic tool for investigation of septic bone infection in presence of hip arthroplasty, presenting a senstitivity of 100% and spesitivity of 93,75%. Proper patient selection, based on diagnostic criteria and risk factors is essential.
Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.